Cathepsin D protects against alpha-synuclein aggregation and toxicity
Author Information
Author(s): Qiao Liyan, Hamamichi Shusei, Caldwell Kim A, Caldwell Guy A, Yacoubian Talene A, Wilson Scott, Xie Zuo-Lei, Speake Lisa D, Parks Rachael, Crabtree Donna, Liang Qiuli, Crimmins Stephen, Schneider Lonnie, Uchiyama Yasuo, Iwatsubo Takeshi, Zhou Yi, Peng Lisheng, Lu YouMing, Standaert David G, Walls Ken C, Shacka John J, Roth Kevin A, Zhang Jianhua
Primary Institution: University of Alabama at Birmingham
Hypothesis
The study investigates the role of lysosomal enzyme cathepsin D in regulating alpha-synuclein accumulation and toxicity.
Conclusion
Cathepsin D overexpression reduces alpha-synuclein aggregation and protects against cell death induced by alpha-synuclein.
Supporting Evidence
- Cathepsin D deficiency leads to significant accumulation of alpha-synuclein in neurons.
- Overexpression of cathepsin D reduces alpha-synuclein aggregation in vitro.
- Cathepsin D protects against alpha-synuclein-induced cell death in mammalian cells.
- RNAi knockdown of cathepsin D in C. elegans worsens alpha-synuclein aggregation.
- Cathepsin D's protective effects are specific and require its enzymatic activity.
Takeaway
Cathepsin D helps keep a brain protein called alpha-synuclein from clumping up and causing problems, which is important for diseases like Parkinson's.
Methodology
The study used mouse models and C. elegans to analyze the effects of cathepsin D on alpha-synuclein accumulation and toxicity.
Limitations
The study primarily focuses on specific models and may not fully represent all aspects of human neurodegenerative diseases.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website